Pengembangan dan penerapan cincin penutup oksidatif selektif dengan banyak gugus sulfhidril

Pengembangan dan penerapan cincin penutup oksidatif selektif dengan banyak gugus sulfhidril

Research background and challenges

Selective ring closure of multiple sulfhydryl compounds is a key step in the synthesis of sulfur-containing heterocyclic compounds, but the traditional method has the following problems:

  • Multiple sulfhydryl reaction activities are similar, making it difficult to achieve selective control. Many side reactions, complex products, and difficult to isolate and purify. The reaction conditions are harsh and the scope of application is limited. We have successfully developed a new selective oxidative ring-closing technology, which completely solves the above problems and achieves efficient and precise ring-closing reaction.

Technical breakthroughs

  • Innovative oxidation system: The first alkyne amide-based oxidation system is proposed, which significantly improves the selectivity.
  • Unique reaction design: through a variety of different positions of the sulfhydryl substrate, the precise ring closure of multiple sulfhydryl substrates is achieved.

Technical Advantages

  • High selectivity: precise identification of target sites among multiple sulfhydryl substrates to achieve single product generation.
  • High efficiency: the reaction conditions are mild, and the reaction yield is significantly improved.
  • Universality: applicable to the synthesis of various sulfur-containing heterocyclic compounds.

Application Fields

  • Drug synthesis: construction of sulfur-containing heterocyclic drug molecules (e.g., thiophene, benzothiophene, dithiopyrrolidine, etc.).
  • Functional materials: preparation of sulfur-containing polymer materials (misalnya. self-repairing materials, conductive polymers, etc.).
  • Chemical biology: study the formation and function of protein disulfide bonds.

admin Avatar

Xiaoxia Chen

Obat Baru R&D Teknisi Keahlian Inti: Penemuan sasaran, hubungan struktur-aktivitas (SAR) analisa, konjugat obat-peptida (PDC), dan pengembangan peptida anti penuaan dan metabolik.

Profil: Xiaoxia Chen telah memimpin penemuan awal dan penelitian praklinis untuk beberapa obat peptida yang menargetkan metabolisme dan tumor. Dia tidak hanya mahir dalam penyaringan perpustakaan peptida dengan throughput tinggi, tetapi juga terampil dalam memanfaatkan biologi komputasi berbantuan AI untuk desain urutan peptida de novo.. Saat ini, dia memimpin tim yang didedikasikan untuk penelitian mendalam dan pengembangan agonis multifungsi generasi berikutnya (seperti ganda- atau peptida pengurang lemak tiga target) dan peptida perbaikan jaringan yang sangat aktif.

Fakta Diperiksa & Pedoman Redaksi
Ditinjau oleh: Pakar Materi Pokok
Bagikan artikel ini
Rumah Mencari ada apa Layanan Produk